This site is intended for health professionals only

At the heart of general practice since 1960

VTE treatments

Selecting an anticoagulant for your patient with VTE requires careful consideration. Below, Dr Nigel Rowell explains the available options and the rationale for his decision making.

Choosing the right treatment for your patients with VTE

In VTE treatments: NOACs for the treatment and prevention of recurrent VTE | What are the characteristics of the different NOAC? | What are the efficacy and safety profiles of NOACs?

Click here to view ELIQUIS (apixaban) prescribing and adverse event reporting information.


NOAC = Non-vitamin K antagonist Oral Anticoagulant VTE = Venous Thromboembolism

Job code: 432UK1900506-01
Date of preparation: September 2019

BMS  Pfizer stacked Logo